Get the Stockscreener App
5.70
3.83%
0.21
After Hours:
5.88
0.18
+3.16%
Health Catalyst Inc Stock (HCAT) Forecast
The Health Catalyst Inc (HCAT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.1685, representing a -61.96% decrease from the current price of $5.70. The highest analyst price target is $1.5057, and the lowest is $2.8313.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HCAT Price Target
Average 15.97
(+180.16% Upside)
Is Health Catalyst Inc (HCAT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.87 | Neutral |
| STOCH(9,6) | 50.82 | Neutral |
| STOCHRSI(14) | 89.01 | Sell |
| MACD(12,26) | -0.3644 | Buy |
| ADX(14) | 32.44 | Sell |
| William %R | -37.72 | Neutral |
| CCI(14) | -4.1545 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.643
Buy
|
5.6867
Buy
|
| MA20 |
5.7655
Sell
|
5.9208
Sell
|
| MA50 |
6.9557
Sell
|
6.6038
Sell
|
| MA100 |
7.5435
Sell
|
7.0458
Sell
|
| MA200 |
7.1427
Sell
|
7.4099
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, HCAT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on HCAT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.87 indicates that HCAT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 50.82 indicates that HCAT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 89.01 indicates that HCAT is oversold. This suggests that HCAT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.44 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -4.1545 indicates that HCAT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HCAT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Health Catalyst Inc financial reports and earnings history, Health Catalyst Inc (HCAT) stock could reach $32.82 by 2030, $17.24 by 2040 and $47.99 by 2050. See the projected annual prices until 2050 of the Health Catalyst Inc stock below:
- Health Catalyst Inc (HCAT) is expected to reach an average price of $5.0938 in 2035, with a high prediction of $4.1038 and a low estimate of $4.4515. This indicates an $-10.63% rise from the last recorded price of $5.70.
- Health Catalyst Inc (HCAT) stock is projected to chart a bullish course in 2040, with an average price target of $16.24, representing an $184.83% surge from its current level. The forecast ranges from a conservative $17.20 to a sky-high $17.24.
- Our analysts predict Health Catalyst Inc (HCAT) to jump 404.25% by 2045, soaring from $29.30 to an average price of $28.74, potentially reaching $28.81. While $29.30 is the low estimate, the potential upside is significant.
- Health Catalyst Inc (HCAT) stock is expected to climb by 2050, reaching an average of $47.29, a $729.71% jump from its current level. However, a wide range of estimates exists, with high and low targets of $47.99 and $47.50, respectively, highlighting the market's uncertainty.
Health Catalyst Inc Stock (HCAT) Year by Year Forecast
Health Catalyst Inc Stock (HCAT) Price Forecast for 2025
Health Catalyst Inc Stock (HCAT) is expected to reach an average price of $10.93 in 2025, with a high prediction of $21.60 and a low estimate of $0.266. This indicates an +91.77% rise from the last recorded price of $5.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $2.4769 | $2.8313 | $1.5057 | -56.55% |
| April, 2025 | $1.6452 | $0.4364 | $3.3519 | -71.14% |
| May, 2025 | $2.3629 | $0.266 | $6.8134 | -58.55% |
| June, 2025 | $9.5605 | $1.7473 | $10.34 | +67.73% |
| July, 2025 | $4.6426 | $3.3527 | $10.83 | -18.55% |
| August, 2025 | $10.45 | $4.497 | $11.17 | +83.34% |
| September, 2025 | $10.74 | $7.8347 | $11.88 | +88.38% |
| October, 2025 | $9.79 | $6.6497 | $12.22 | +71.75% |
| November, 2025 | $12.56 | $8.0044 | $13.11 | +120.31% |
| December, 2025 | $20.84 | $12.65 | $21.60 | +265.61% |
Health Catalyst Inc Stock (HCAT) Price Forecast for 2026
The predicted value for Health Catalyst Inc (HCAT) in 2026 is set at an average of $29.22. Estimates vary from a peak of $38.65 to a trough of $19.79, indicating an +412.63% surge from the present price of $5.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $28.39 | $20.11 | $29.28 | +398.02% |
| February, 2026 | $23.09 | $20.71 | $31.67 | +305.00% |
| March, 2026 | $24.03 | $22.40 | $26.86 | +321.63% |
| April, 2026 | $35.63 | $23.55 | $36.83 | +525.17% |
| May, 2026 | $31.80 | $24.79 | $36.45 | +457.94% |
| June, 2026 | $35.95 | $30.24 | $37.80 | +530.70% |
| July, 2026 | $36.14 | $32.17 | $38.05 | +534.07% |
| August, 2026 | $29.21 | $28.57 | $38.65 | +412.45% |
| September, 2026 | $35.18 | $29.63 | $37.00 | +517.23% |
| October, 2026 | $27.14 | $26.96 | $35.21 | +376.13% |
| November, 2026 | $32.31 | $25.80 | $34.84 | +466.79% |
| December, 2026 | $19.94 | $19.79 | $33.15 | +249.81% |
Health Catalyst Inc Stock (HCAT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Health Catalyst Inc (HCAT) is $11.38, with a high forecast of $22.70 and a low forecast of $0.0573. This indicates an +99.60% increase from the last price of $5.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.04 | $17.18 | $22.70 | +269.07% |
| February, 2027 | $10.14 | $8.5347 | $22.16 | +77.98% |
| March, 2027 | $9.4767 | $6.0467 | $13.16 | +66.26% |
| April, 2027 | $7.6544 | $3.0344 | $10.63 | +34.29% |
| May, 2027 | $7.1121 | $6.6988 | $11.00 | +24.77% |
| June, 2027 | $0.3759 | $0.1597 | $8.5565 | -93.41% |
| July, 2027 | $1.2482 | $2.0826 | $1.3926 | -78.10% |
| August, 2027 | $1.2605 | $1.3105 | $2.3694 | -77.89% |
| September, 2027 | $1.4615 | $0.0573 | $2.1383 | -74.36% |
| October, 2027 | $2.8608 | $3.1708 | $3.116 | -49.81% |
| November, 2027 | $4.2031 | $3.4264 | $2.9431 | -26.26% |
| December, 2027 | $5.3511 | $4.7899 | $4.5955 | -6.12% |
Health Catalyst Inc Stock (HCAT) Price Forecast for 2028
In 2028, Health Catalyst Inc (HCAT) is projected to reach an average price of $2.393, with a high projection of $4.7565 and a low estimate of $0.0296. This indicates an -58.02% fall from the last price of $5.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.8534 | $5.0722 | $4.6422 | -32.40% |
| February, 2028 | $2.6357 | $2.9257 | $3.4546 | -53.76% |
| March, 2028 | $2.0337 | $2.9237 | $2.2481 | -64.32% |
| April, 2028 | $1.454 | $0.0296 | $1.789 | -74.49% |
| May, 2028 | $1.9861 | $0.8834 | $2.6316 | -65.16% |
| June, 2028 | $0.0463 | $0.3751 | $3.9905 | -99.19% |
| July, 2028 | $1.9014 | $0.2974 | $2.1214 | -66.64% |
| August, 2028 | $0.2935 | $0.2565 | $2.1558 | -94.85% |
| September, 2028 | $1.8011 | $0.3179 | $2.3011 | -68.40% |
| October, 2028 | $2.3088 | $0.9544 | $2.6494 | -59.49% |
| November, 2028 | $3.3409 | $2.2532 | $4.7565 | -41.39% |
| December, 2028 | $2.5785 | $1.9341 | $3.7793 | -54.76% |
Health Catalyst Inc Stock (HCAT) Price Forecast for 2029
The 2029 price forecast for Health Catalyst Inc Stock (HCAT) is $15.13 on average, with a high prediction of $30.16 and a low estimate of $0.1087. This represents an +165.50% increase from the previous price of $5.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1806 | $0.4862 | $2.933 | -79.29% |
| February, 2029 | $0.8017 | $0.255 | $1.385 | -85.93% |
| March, 2029 | $0.264 | $0.394 | $0.5115 | -95.37% |
| April, 2029 | $1.2136 | $0.2408 | $1.4636 | -78.71% |
| May, 2029 | $2.1657 | $1.108 | $4.2513 | -62.01% |
| June, 2029 | $3.1134 | $2.3001 | $4.0201 | -45.38% |
| July, 2029 | $1.751 | $0.7622 | $3.7178 | -69.28% |
| August, 2029 | $0.7431 | $0.6831 | $2.9854 | -86.96% |
| September, 2029 | $0.7608 | $0.1087 | $1.1525 | -86.65% |
| October, 2029 | $17.50 | $0.8052 | $23.48 | +207.08% |
| November, 2029 | $25.91 | $21.72 | $22.23 | +354.53% |
| December, 2029 | $30.22 | $27.37 | $30.16 | +430.23% |
Health Catalyst Inc Stock (HCAT) Price Forecast for 2030
Health Catalyst Inc Stock (HCAT) is expected to reach an average price of $25.36 in 2030, with a high forecast of $32.82 and a low forecast of $17.90. This signifies an +344.86% surge from the last price of $5.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $29.01 | $31.38 | $32.82 | +408.92% |
| February, 2030 | $22.81 | $27.08 | $26.39 | +300.23% |
| March, 2030 | $25.17 | $22.46 | $25.16 | +341.54% |
| April, 2030 | $21.72 | $24.61 | $22.87 | +281.10% |
| May, 2030 | $26.84 | $24.96 | $24.50 | +370.85% |
| June, 2030 | $33.94 | $28.19 | $28.61 | +495.50% |
| July, 2030 | $31.01 | $31.62 | $31.96 | +444.02% |
| August, 2030 | $30.12 | $30.52 | $29.34 | +428.49% |
| September, 2030 | $27.39 | $26.93 | $27.26 | +380.50% |
| October, 2030 | $24.43 | $25.48 | $25.20 | +328.67% |
| November, 2030 | $16.86 | $17.90 | $22.54 | +195.77% |
| December, 2030 | $20.16 | $18.17 | $19.14 | +253.75% |
0.00%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):